Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Abhishek Gairola
Institution:
Newcastle upon Tyne Hospitals NHS Foundation Trust
Observed institutions:
Northumbria Healthcare NHS Foundation Trust,
Newcastle upon Tyne Hospitals NHS Foundation Trust,
Freeman Hospital,
Newcastle University
ORCID:
0009-0006-0794-5789
Observed ORCID:
0009-0006-0794-5789
OpenAlex ID:
A5077370230
Sodium/bile acid co-transporter inhibitors currently in preclinical or early clinical development for the treatment of primary biliary cholangitis
2024
·
Abhishek Gairola
, Aaron Wetten
, et al.
·
Expert Opinion on Investigational Drugs
·
5
P222 Safety, tolerability and efficacy of rituximab in patients with challenging autoimmune hepatitis: results from a tertiary UK liver unit
2025
·
Abhishek Gairola
, Jessica Dyson
·
Gut
·
1
THU-159-YI Assessing the safety, tolerability and efficacy of rituximab in patients with difficult-to-treat autoimmune hepatitis: results from a tertiary UK liver unit
2024
·
Abhishek Gairola
, Jessica Dyson
·
Journal of Hepatology
·
1
P31 Safety, tolerability and efficacy of elafibranor use in patients with primary biliary cholangitis
2026
·
Rie Torimaru
, Abhishek Gairola
, et al.
·
Gut
PDF
SAT-368-YI ALNE 2.0: a histopathology-based deep learning model accurately discriminates autoimmune hepatitis and primary biliary cholangitis and helps identify the dominant phenotype in variant cases
2026
·
Elisa Merelli
, Laura Žigutytė
, et al.
·
Journal of Hepatology
P37 Assessing the impact of vitamin D status on disease status over 12 months in patients newly diagnosed with autoimmune hepatitis
2025
·
Abhishek Gairola
, Lin Lee Wong
, et al.
·
Gut
PWE-40 Improving care of patients with Hereditary Haemochromatosis (HH) – A review from a large DGH
2021
·
Abhishek Gairola
, Deepak Kejariwal
·
Gut
PDF
Show more works
View as search
Works count:
7
Citation count:
7
H-index:
1
I10-index:
Year
Topic
Type